RDEC

  • Twitter
  • Linkedin
RDEC

Synthetic Biology: market drivers, challenges and R&D opportunities

Synthetic biology (or SynBio) is an exciting intersection of biology and engineering, which promises to tackle some of the world’s most pressing challenges. The UK Government believes SynBio could even revolutionise key sectors, including food security, healthcare, and sustainability. As well as the social benefits, UK advances in SynBio could also deliver significant economic rewards, […]

Navigating the 2023 changes to R&D Expenditure Credit (RDEC)

Significant changes to the RDEC scheme, including more generous RDEC rate changes, came into effe...

FinTech companies UK R&D Tax Credit expenditure

We’ve reviewed the stats behind R&D Tax Credit claims for FinTech companies, specifically loo...

Leyton For Me – Online R&D Tax Credits software to simplify your claim

Discover how Leyton For Me, our online R&D Tax Credits software platform, simplifies HMRC's c...

Autumn Statement 2022: What it means for R&D Tax Relief

April 2023 R&D Tax Relief reform: Implications for R&D businesses

Following the conclusion of the consultation regarding the draft legislation for the forthcoming ...

Avoid HMRC enquiries on your R&D Claim

In this article, Ross Howarth looks at what may lie behind the increasing number of fraudulent R&...

Artificial Intelligence – panacea or pipe dream?

Artificial Intelligence – panacea or pipe dream?

Leyton panel debates fast-evolving AI and machine-learning landscape.